Kedem Pharmaceuticals (GHLV) 10-Q 2010 Q3 Quarterly report

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of Global Health Ventures Inc., on Form 10-Q for the period ending February 28, 2010, as filed with the Securities and Exchange Commission on the date hereof, I, Audrey Lew, Chief Financial Officer of Global Health Ventures Inc., certifies to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1)   Such Quarterly Report on Form 10-Q for the period February 28, 2010, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)   The information contained in such Quarterly Report on Form 10-Q for the period ending February 28, 2010, fairly presents, in all material respects, the financial condition and results of operations of Global Health Ventures Inc.

Date: April 14, 2010	/s/ Audrey Lew
	Audrey Lew
	Chief Financial Officer